Treating aged WT or adult Sod1−/− mice with necrostatin-1s, a RIPK1 inhibitor, reduces liver inflammation and MASH pathology, underscoring the necroptosis pathway’s role in age-related liver inflammation and MASH. The gene discussed is RIPK1; the disease is inflammatory response.